Recurrent Campylobacter Bacteraemia in Immunocompromised Patients

Not yet recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

May 1, 2025

Study Completion Date

May 1, 2026

Conditions
Campylobacter Infections
Interventions
OTHER

Characteristics of patients and Campylobacter bacteraemia episodes

Variables: characteristics of the patients (demographic characteristics; characteristics of immunodeficiency: diagnosis, immunoglobulin dosage, white cells count etc.; chronic inflammatory bowel disease \[IBD\]), the bacteria (species, antimicrobial susceptibility) and the infection (clinical presentation, evolution, treatment received)

Trial Locations (1)

69004

Infectious diseases department, Hospital de la Croix Rousse,, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT06432777 - Recurrent Campylobacter Bacteraemia in Immunocompromised Patients | Biotech Hunter | Biotech Hunter